Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06989775 · ClinicalTrials.gov registry record · NA
BoxX-NoAF Clinical Trial
A NA study of Post Operative Atrial Fibrillation and Atrial Fibrillation, Postoperative, sponsored by AtriCure.
- Recruiting
- Registry status
- NA
- Development phase
- 960
- Enrollment target
- 10
- Study locations
NCT06989775 is a NA study of Post Operative Atrial Fibrillation and Atrial Fibrillation, Postoperative that is actively recruiting participants, run by AtriCure. The registered enrollment target is 960 participants. The trial reports 10 study locations across 8 states.
The verdict
NCT06989775, a NA study of Post Operative Atrial Fibrillation and Atrial Fibrillation, Postoperative, is actively recruiting participants, sponsored by AtriCure.
- RECRUITING
- Registry status
- NA
- Development phase
- 960 participants
- Enrollment target
- 10
- Study locations
Study Summary
Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial to evaluate if prophylactic ablation and exclusion of the Left Atrial Appendage at the time of other routine cardiac surgery can reduce the incidence of post operative AF and clinical AF during long term follow up in patients who have not yet developed AF but are at risk.
Conditions Studied
Interventions
- DEVICE Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System
Study Locations (10)
Florida
- Morton Plant Hospital - BayCare Health System, Inc. - Clearwater
- St. Joseph's Hospital - BayCare Health System, Inc. - Clearwater
- Orlando Health, Inc. - Orlando
Arkansas
- St. Bernards Medical Center - Jonesboro
Georgia
- Wellstar Health System - Marietta
Michigan
- Corewell Health - Grand Rapids
Minnesota
- Mayo Clinic - Rochester
New York
- New York Presbyterian Hospital/Columbia University Irving Medical Center - New York
Tennessee
- Ascension Saint Thomas - Nashville
Ontario
- Hamilton General Hospital - Hamilton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2031-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06989775
The ClinicalTrials.gov registry entry for NCT06989775 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Post Operative Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System is the first listed.
NCT06989775 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, Arkansas, Georgia.
Frequently Asked Questions
What is clinical trial NCT06989775 about?
NCT06989775 is a clinical study titled "BoxX-NoAF Clinical Trial". Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial...
What is the current status of trial NCT06989775?
This trial is currently recruiting. It is a NA study. The enrollment target is 960 participants. The study started on 2025-10-24. Estimated completion is 2031-11.
What conditions does trial NCT06989775 study?
This clinical trial studies the following conditions: Post Operative Atrial Fibrillation, Atrial Fibrillation, Postoperative.
What interventions are being tested in trial NCT06989775?
The interventions under investigation include: Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System (DEVICE).
Who is sponsoring clinical trial NCT06989775?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06989775 being conducted?
This trial has 10 study locations across Arkansas, Florida, Georgia, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Post Operative Atrial Fibrillation
All registered trials for this condition
Atrial Fibrillation, Postoperative
All registered trials for this condition
Arkansas
All trials with a study site in Arkansas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.